Purdue University scientists have identified the Supinoxin small-molecule drug as a possible new therapy for small-cell lung ...

The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...

Summit Therapeutics shares rallied after its lung cancer drug candidate showed that it improved patients' longevity without the disease worsening in a late-stage trial. Shares of Summit rose 11% to ...

This study suggests that immunotherapy may not be the optimal ... New, Rare Type of Small Cell Lung Cancer Identified Sep. 11, 2024 — A team of doctors and researchers have identified a new ...

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

“The CE Mark approval for Optune Lua for metastatic non-small cell lung ... in multiple tumor types that have historically been very difficult to treat, including lung cancer.

The study advanced beyond a one-size-fits-all model by developing both a global XGBoost classifier and cancer-type-specific ...

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.

Preventing this complication for those who receive a lung transplant is of the highest priority, as there ... Experimental Cancer Drug ... and activating a type of immune cell known as B cells ...